AI Designs a Novel PROTAC from Scratch: Insilico's generative AI platform, Chemistry42, successfully designed a first-in-class PROTAC targeting PKMYT1 by creating an entirely new inhibitor and its ...
SAN FRANCISCO , CA, UNITED STATES, March 30, 2026 /EINPresswire.com/ — Ainnocence, a next-generation AI drug discovery company, announces the commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results